Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients

Kidney transplant recipients develop secondary osteoporosis induced by immunosuppressive medication, with a high risk of fracture, and abdominal aortic calcification (AC) is a known predictor of cardiovascular mortality. In this study of 12 stable kidney recipients, we estimated the preventive effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Masanori, Yamanaka, Shintaro, Yoshimoto, Wataru, Shigematsu, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945217/
https://www.ncbi.nlm.nih.gov/pubmed/24696777
http://dx.doi.org/10.1155/2014/269613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945217/
https://www.ncbi.nlm.nih.gov/pubmed/24696777
http://dx.doi.org/10.1155/2014/269613

Ejemplares similares